Showing 1151-1160 of 1308 results for "".
- Orasis Pharmaceuticals Appoints Julie Speed as Senior Vice President, Head of Strategy and Marketing to Lead Commercial Growth Planhttps://modernod.com/news/orasis-pharmaceuticals-appoints-julie-speed-as-senior-vice-president-head-of-strategy-and-marketing-to-lead-commercial-growth-plan/2480321/Orasis Pharmaceuticals announced the appointment of Julie Speed as senior vice president (SVP), head of strategy and marketing. Ms. Speed brings over two decades of leadership in eye care and will be responsible for developing the brand strategy and building the marketin
- Horizon Therapeutics Partners With Olympic Gold Medalist Gail Devers to Raise Awareness of Graves’ Disease and Symptoms of Thyroid Eye Disease (TED)https://modernod.com/news/horizon-therapeutics-partners-with-olympic-goldmmedalist-gail-devers-to-raise-awareness-of-graves-disease-and-symptoms-of-thyroid-eye-disease-ted/2479357/For Graves’ Disease Awareness Month in July, Horizon Therapeutics is teaming up with track star and three-time Olympic gold medalist Gail Devers, who has been living with Graves’ disease and symptoms of Thyroid Eye Disease (TED) for more than 30 years. Horizon and Ms. Devers are collaborating wit
- Jasmine Pachnanda Named Senior Vice President for CEO Leadership Alliance; Will Lead SoCal AI Initiativehttps://modernod.com/news/jasmine-pachnanda-named-senior-vice-president-for-ceo-leadership-alliance-will-lead-socal-ai-initiative/2479012/The CEO Leadership Alliance – Orange County (CLA-OC) has named Jasmine Pachnanda as Senior Vice President. Ms. Pachnanda will work with a range of partners and stakeholders, harnessing efforts to grow and demonstrate Southern California’s emerging leadership as a worldwide center for
- Lexitas Announces George N. Magrath, MD, MBA Assumes Role of Chief Executive Officerhttps://modernod.com/news/lexitas-announces-george-n-magrath-md-mba-assumes-role-of-chief-executive-officer/2478905/George N. Magrath, MD, MBA, MS, has been named CEO of Lexitas Pharma Services. Chad Ice will transition from the role as CEO to President with a focus on strategic growth initiatives as well as the expansion of the Lexitas Board of Directors. These changes became effective February 1, 2021. <
- Tarsus Pharmaceuticals Appoints Wendy Yarno to Board of Directorshttps://modernod.com/news/tarsus-pharmaceuticals-appoints-wendy-yarno-to-board-of-directors/2478584/Tarsus Pharmaceuticals announced the appointment of Wendy L. Yarno to its Board of Directors and its audit committee. Ms. Yarno has more than 30 years of experience in the biopharmaceutical industry, as a public company director and product commercialization leader, including 26 years at Merck &a
- Genentech to Present New Data in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder at MSVirtual2020https://modernod.com/news/genentech-to-present-new-data-in-multiple-sclerosis-and-neuromyelitis-optica-spectrum-disorder-at-msvirtual2020/2478238/Genentech announced that new multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) data will be presented at MSVirtual2020, the 8th Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) – European Committee for Treatment and Research in Mul
- Oculis Establishes Presence in US and Appoints Sylvia Cheung as Chief Financial Officerhttps://modernod.com/news/oculis-establishes-presence-in-us-and-appoints-sylvia-cheung-as-chief-financial-officer/2478231/Oculis established a US entity, Oculis Inc., and announced the appointment of Sylvia Cheung as Chief Financial Officer (CFO). Ms. Cheung will be based in the newly established Oculis US entity and succeeds Páll Ragnar Jóhannesson who becomes Oculis Chief Strategy Officer. “We are very plea
- American Academy of Optometry Foundation Announces the 2020 Alfred A. Rosenbloom Jr. Low Vision Residency Award Recipienthttps://modernod.com/news/american-academy-of-optometry-foundation-announces-the-2020-alfred-a-rosenbloom-jr-low-vision-residency-award-recipient/2478194/The American Academy of Optometry has announced that Carolyn N. Chakuroff, OD, MS, is this year’s recipient of the Alfred A. Rosenbloom Jr. Low Vision Residency Award. Dr. Chakuroff is a graduate of The Ohio State University College of Optometry and an Ocular Disease/Low Vision Rehabilitation res
- Johnson & Johnson Vision Appoints Erin McEachren as Regional Vice President, Surgical, EMEAhttps://modernod.com/news/johnson-johnson-vision-appoints-erin-mceachren-as-regional-vice-president-surgical-emea/2477847/Johnson & Johnson Vision has appointed Erin McEachren to the position of Regional Vice President for Johnson & Johnson Surgical Vision, EMEA. In this role, Ms. McEachren will lead Johnson & Johnson’s high-performance surgical vision team to address the unmet needs of patients and eye
- Eyevance Pharmaceuticals Appoints Julie Speed as Chief Commercial Officerhttps://modernod.com/news/eyevance-pharmaceuticals-appoints-julie-speed-as-chief-commercial-officer/2477316/Eyevance Pharmaceuticals has appointed Julie Speed to the position of Chief Commercial Officer. In her new role, Ms. Speed will be responsible for developing the commercial strategy and overseeing the growth of Eyevance’s product portfolio, including Flarex (fluorometholone acetate) 0.1%, Freshk